Akso Historical Financial Ratios
| AHG Stock | USD 1.23 0.12 10.81% |
Akso Health is presently reporting on over 92 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.088, PTB Ratio of 0.35 or Days Sales Outstanding of 182 will help investors to properly organize and evaluate Akso Health Group financial condition quickly.
Akso |
About Akso Financial Ratios Analysis
Akso Health GroupFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Akso Health investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Akso financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Akso Health history.
Akso Health Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Akso Health Group stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Akso Health sales, a figure that is much harder to manipulate than other Akso Health Group multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Akso Health Group dividend as a percentage of Akso Health stock price. Akso Health Group dividend yield is a measure of Akso Health stock productivity, which can be interpreted as interest rate earned on an Akso Health investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Stock Based Compensation To Revenue
A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.Most ratios from Akso Health's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Akso Health Group current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akso Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. At this time, Akso Health's Inventory Turnover is most likely to increase in the upcoming years. The Akso Health's current Days Of Inventory On Hand is estimated to increase to 31.97, while Days Sales Outstanding is projected to decrease to 182.23.
| 2023 | 2024 (projected) | Dividend Yield | 0.0995 | 0.088 | Price To Sales Ratio | 21.27 | 28.74 |
Akso Health fundamentals Correlations
Click cells to compare fundamentals
Akso Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Akso Health fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 1.79 | 16.33 | 5.32 | 0.62 | 21.27 | 28.74 | |
| Ptb Ratio | 0.43 | 1.66 | 2.73 | 0.93 | 0.37 | 0.35 | |
| Days Sales Outstanding | 1.0K | 2.2K | 1.2K | 213.13 | 191.82 | 182.23 | |
| Book Value Per Share | 2.96 | 1.06 | 0.62 | 0.39 | 3.07 | 2.93 | |
| Free Cash Flow Yield | (2.74) | 0.35 | (0.26) | (0.4) | 0.0263 | 0.0276 | |
| Operating Cash Flow Per Share | (3.44) | 0.62 | (0.43) | (0.14) | 0.03 | 0.0285 | |
| Stock Based Compensation To Revenue | 0.11 | 0.0304 | 0.0316 | 0.0621 | 0.0558 | 0.0398 | |
| Capex To Depreciation | 2.62 | 2.32 | 0.54 | 0.26 | 0.3 | 0.29 | |
| Pb Ratio | 0.43 | 1.66 | 2.73 | 0.93 | 0.37 | 0.35 | |
| Ev To Sales | 2.65 | 13.4 | 7.74 | 0.75 | (13.18) | (12.52) | |
| Free Cash Flow Per Share | (3.46) | 0.62 | (0.43) | (0.14) | 0.03 | 0.0285 | |
| Roic | (0.58) | (1.01) | (1.24) | (0.77) | (0.0617) | (0.0648) | |
| Inventory Turnover | (1.28E-4) | (0.0379) | 0.69 | 7.06 | 11.99 | 12.59 | |
| Net Income Per Share | (4.38) | (1.94) | (0.85) | (0.57) | (0.21) | (0.22) | |
| Days Of Inventory On Hand | (2.9M) | (9.6K) | 527.44 | 51.67 | 30.45 | 31.97 | |
| Sales General And Administrative To Revenue | 2.34 | 15.54 | 2.44 | 1.18 | 3.56 | 2.06 | |
| Capex To Revenue | 0.004252 | 0.0154 | 0.0275 | 7.7E-4 | 8.86E-4 | 8.41E-4 | |
| Cash Per Share | 0.67 | 0.93 | 1.1 | 0.35 | 1.89 | 2.01 | |
| Pocfratio | (0.37) | 2.85 | (3.89) | (2.5) | 38.0 | 36.65 | |
| Capex To Operating Cash Flow | 0.005199 | (0.55) | (0.00563) | (5.63E-4) | (6.48E-4) | (6.8E-4) | |
| Pfcf Ratio | (0.36) | 2.85 | (3.89) | (2.5) | 38.0 | 43.53 | |
| Income Quality | 0.78 | (0.29) | 0.51 | 0.25 | (0.15) | (0.16) | |
| Roe | (1.48) | (1.83) | (1.37) | (1.5) | (0.0684) | (0.0718) | |
| Ev To Operating Cash Flow | (0.54) | 2.34 | (5.66) | (3.04) | (23.55) | (22.38) | |
| Pe Ratio | (0.29) | (0.91) | (1.99) | (0.62) | (5.43) | (5.7) | |
| Return On Tangible Assets | (0.45) | (1.0) | (0.33) | (0.64) | (0.0666) | (0.0699) | |
| Ev To Free Cash Flow | (0.54) | 2.34 | (5.66) | (3.04) | (23.55) | (22.38) | |
| Earnings Yield | (3.48) | (1.1) | (0.5) | (1.61) | (0.18) | (0.19) | |
| Net Debt To E B I T D A | (0.52) | 2.48 | (4.68) | (0.12) | 9.79 | 10.27 | |
| Current Ratio | 4.91 | 2.09 | 1.32 | 1.78 | 39.52 | 41.49 | |
| Tangible Book Value Per Share | 7.91 | 1.06 | 0.62 | 0.39 | 3.07 | 3.48 | |
| Receivables Turnover | 0.36 | 0.17 | 0.32 | 1.71 | 1.97 | 1.87 | |
| Graham Number | 17.08 | 6.8 | 3.43 | 2.22 | 3.81 | 3.62 | |
| Shareholders Equity Per Share | 2.96 | 1.06 | 0.62 | 0.38 | 3.07 | 2.93 | |
| Capex Per Share | 0.0287 | 0.0536 | 0.0194 | 2.45E-4 | 2.2E-4 | 2.09E-4 |
Currently Active Assets on Macroaxis
When determining whether Akso Health Group is a strong investment it is important to analyze Akso Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Akso Health's future performance. For an informed investment choice regarding Akso Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akso Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akso Health. If investors know Akso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akso Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.21) | Revenue Per Share 0.051 | Quarterly Revenue Growth 0.148 | Return On Assets (0.07) | Return On Equity (0.12) |
The market value of Akso Health Group is measured differently than its book value, which is the value of Akso that is recorded on the company's balance sheet. Investors also form their own opinion of Akso Health's value that differs from its market value or its book value, called intrinsic value, which is Akso Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akso Health's market value can be influenced by many factors that don't directly affect Akso Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akso Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akso Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akso Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.